G-CSF for Neutropenia (Primary) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About G-CSF for Neutropenia (Primary)
Primary neutropenia is a rare blood disorder where the body produces too few infection-fighting neutrophils. Granulocyte-colony stimulating factor (G-CSF) is a crucial, often lifelong, treatment. These medications can be very expensive, creating significant financial stress. TheDrugClub helps members afford vital G-CSF prescriptions, ensuring consistent access to care without breaking the bank.
Primary neutropenia refers to a group of rare blood disorders characterized by persistently low levels of neutrophils, a critical type of white blood cell responsible for fighting off bacterial and fungal infections. This condition can be congenital, meaning it's present from birth (e.g., severe congenital neutropenia or SCN), or idiopathic, with no identifiable cause. Regardless of its origin, individuals with primary neutropenia are at a significantly increased risk for recurrent, severe infections that can be life-threatening if not properly managed.
The cornerstone of treatment for many forms of primary neutropenia is Granulocyte-Colony Stimulating Factor, or G-CSF. This medication is a synthetic version of a natural protein that stimulates the bone marrow to produce more neutrophils. Common G-CSF medications include filgrastim (brand names like Neupogen, Zarxio, Nivestym) and pegfilgrastim (Neulasta, Fulphila, Udenyca). These biologics are typically administered via injection, often multiple times a week or every few weeks, and
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.